National Meet on Strengthening Pharma covigilance

The Indian Pharmacopoeia Commission (IPC), Ministry of Health and Family Welfare, Government of India, in collaboration with the Andhra Pradesh MedTech Zone (AMTZ) organised a two-day National Meet on Strengthening Pharmacovigilance and Materiovigilance in India on 27-28 February 2026 at Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam. In a first-time ever national meet, the 1st Annual Meeting of Regional Centres participating in the Pharmacovigilance Programme of India (PvPI) and the Materiovigilance Programme of India (MvPI) was organised to strengthen India’s drug and medical device safety systems and enhance coordination among regulators, healthcare institutions, ADR Monitoring Centres (AMCs), and Medical Device Monitoring Centres (MDMCs). Senior officials from regulatory authorities, leading medical institutions, and representatives from the WHO Country Office for India participated in the deliberations.

The inaugural session was presided over by Dr V Kalaiselvan, Secretary-cum-Scientific Director, IPC, who underscored the need to transition from awareness-driven reporting to a performance-oriented pharmacovigilance framework with measurable outcomes. Senior leadership from leading AIIMS institutions, including Prof. Y K Gupta, Prof. Ashok Puranik, along with Dr Jitendra Sharma, Managing Director and Founder CEO, AMTZ, and Dr Kavita Kachroo, CEO, Kalam Institute of Health Technology, participated in the inaugural session and highlighted the importance of institutional collaboration in strengthening pharmacovigilance and materiovigilance systems across the country.

The meet concluded with a reaffirmation of IPC’s commitment to further strengthening India’s pharmacovigilance and materiovigilance ecosystem through coordinated and evidence-based interventions.(UPDATED ON 28TH FEBRUARY 2026)